About Phil Nalbone
Phil Nalbone is a director at Reprise Biomedical.
Phil Nalbone first appears on SEC filings in 2023.
Experience
This experience comes from Phil Nalbone's profile and from SEC filings. For roles taken from filings, the years are when the filings name Phil Nalbone in the role, so the role may have started earlier or lasted longer.
RC
Robert H. Jackson Center Current
Chair of the Board of Directors
2025 – Present
Reprise Biomedical, Inc. Current
Member Board of Directors
2021 – Present · Plymouth, MN
Makes biological wound care devices for physicians treating patients.
IC
Imperative Care Current
Vice President of Corporate Development & Investor Relations
2019 – Present
PA
PEN Research & Analysis
Consultant
2018 – 2019
TI
Teleflex Incorporated
Senior Director, Corporate Development
2017 – 2018
VT
Vascular Solutions - Now part of Teleflex
Vice President-Corporate Development and Investor Relations
2011 – 2017
DJ
Dow Jones Newswires/The Wall Street Journal
Staff Reporter
1987 – 1992
Key Colleagues at Startups
The people Phil Nalbone works with at each company, as listed on that company's latest Form D.
Reprise Biomedical, Inc. · Form D/A, Jul 1, 2026
Jake Isenburg
Vice President of Research and Development
Heather Kotila
Vice President of Human Resources
Jerrod Krueger
Vice President of Manufacturing
Tom Kouchoukos
Vice President of Marketing
HR
Howard Root
Director
Carrie Powers
President and Chief Executive Officer, director
Greg Smock
General Counsel and Chief Compliance Officer
SJ
Steve Jagodzinski
Controller and Treasurer
AW
Alan Woldt
Director
RE
Ronald Eibensteiner
Director
Jeff Duncan
Vice President of Quality
EK
Erwin Kelen
Director